Form CORRESP - Correspondence:
SEC Accession No. 0001140361-24-035029
Filing Date
2024-07-31
Accepted
2024-07-31 07:23:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6390
2 logo_acastipharma.jpg GRAPHIC 1049220
  Complete submission text file 0001140361-24-035029.txt   1452192
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-649-9272
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)